Thomas Ludwig

Thomas Ludwig

Auto-generated profile, based on publicly available information

Thomas Ludwig

Univ Brest, INSERM, EFS, UMR 1078, GGB, Brest, France

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2010 in Bioinformatics
Verified
Journal Article
Open access
PDF file
FJFabrice Jossinet
Fabrice Jossinet
TLThomas E. Ludwig
Thomas E. Ludwig
EWEric Westhof
Eric Westhof
Summary: Assemble is an intuitive graphical interface to analyze, manipulate and build complex 3D RNA architectures. It provides several advanced and unique features within the framework of a semi-automated modeling process that can be performed by homology and ab initio with or without electron density maps. Those include the interactive editing of a secondary structure and a searchable, embedded library of annotated tertiary structures. Assemble helps users with performing recurrent and otherwise tedious tasks in structural RNA research. Availability and Implementation: Assemble is released under an open-source license (MIT license) and is freely available at http://bioinformatics.org/assemble. It is implemented in the Java language and runs on MacOSX, Linux and Windows operating systems. Contact:f.jossinet@ibmc-cnrs.unistra.fr

21 June 2017 in European Journal of Human Genetics
Verified
Journal Article
Closed access
TCthe FREX consortium
the FREX consortium
SGStéphanie Guey
Stéphanie Guey
MKMarkus Kraemer
Markus Kraemer
DHDominique Hervé
Dominique Hervé
TLThomas Ludwig
Thomas Ludwig
ETElisabeth Tournier-Lasserve
Elisabeth Tournier-Lasserve

1 September 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
ECEstelle Colin
Estelle Colin
JDJens Daniel
Jens Daniel
AZAlban Ziegler
Alban Ziegler
JWJamal Wakim
Jamal Wakim
ASAurora Scrivo
Aurora Scrivo
DLDoris Lechner
Doris Lechner

1 February 2020 in The Lancet Rheumatology
Verified
Journal Article
Closed access
ABAlexandre Belot
Alexandre Belot
GRGillian I Rice
Gillian I Rice
SOSulliman Ommar Omarjee
Sulliman Ommar Omarjee
QRQuentin Rouchon
Quentin Rouchon
ESEve M D Smith
Eve M D Smith
FWFiona Wood
Fiona Wood

30 November 2018 in Brain
Verified
Journal Article
Closed access
AKArtem Kim
Artem Kim
CSClara Savary
Clara Savary
CDChristèle Dubourg
Christèle Dubourg
WCWilfrid Carré
Wilfrid Carré
CMCharlotte Mouden
Charlotte Mouden
VDVéronique David
Véronique David
Holoprosencephaly is a pathology of forebrain development characterized by high phenotypic heterogeneity. The disease presents with various clinical manifestations at the cerebral or facial levels. Several genes have been implicated in holoprosencephaly but its genetic basis remains unclear: different transmission patterns have been described including autosomal dominant, recessive and digenic inheritance. Conventional molecular testing approaches result in a very low diagnostic yield and most cases remain unsolved. In our study, we address the possibility that genetically unsolved cases of holoprosencephaly present an oligogenic origin and result from combined inherited mutations in several genes. Twenty-six unrelated families, for whom no genetic cause of holoprosencephaly could be identified in clinical settings [whole exome sequencing and comparative genomic hybridization (CGH)-array analyses], were reanalysed under the hypothesis of oligogenic inheritance. Standard variant analysis was improved with a gene prioritization strategy based on clinical ontologies and gene co-expression networks. Clinical phenotyping and exploration of cross-species similarities were further performed on a family-by-family basis. Statistical validation was performed on 248 ancestrally similar control trios provided by the Genome of the Netherlands project and on 574 ancestrally matched controls provided by the French Exome Project. Variants of clinical interest were identified in 180 genes significantly associated with key pathways of forebrain development including sonic hedgehog (SHH) and primary cilia. Oligogenic events were observed in 10 families and involved both known and novel holoprosencephaly genes including recurrently mutated FAT1, NDST1, COL2A1 and SCUBE2. The incidence of oligogenic combinations was significantly higher in holoprosencephaly patients compared to two control populations (P < 10-9). We also show that depending on the affected genes, patients present with particular clinical features. This study reports novel disease genes and supports oligogenicity as clinically relevant model in holoprosencephaly. It also highlights key roles of SHH signalling and primary cilia in forebrain development. We hypothesize that distinction between different clinical manifestations of holoprosencephaly lies in the degree of overall functional impact on SHH signalling. Finally, we underline that integrating clinical phenotyping in genetic studies is a powerful tool to specify the clinical relevance of certain mutations.

20 January 2023 in Science
Verified
Journal Article
Closed access
MBMandy L. Ballinger
Mandy L. Ballinger
SPSwetansu Pattnaik
Swetansu Pattnaik
PMPiyushkumar A. Mundra
Piyushkumar A. Mundra
MZMilita Zaheed
Milita Zaheed
EREmma Rath
Emma Rath
DTDavid M. Thomas
David M. Thomas
Cancer genetics has to date focused on epithelial malignancies, identifying multiple histotype-specific pathways underlying cancer susceptibility. Sarcomas are rare malignancies predominantly derived from embryonic mesoderm. To identify pathways specific to mesenchymal cancers, we performed whole-genome germline sequencing on 1644 sporadic cases and 3205 matched healthy elderly controls. Using an extreme phenotype design, a combined rare-variant burden and ontologic analysis identified two sarcoma-specific pathways involved in mitotic and telomere functions. Variants in centrosome genes are linked to malignant peripheral nerve sheath and gastrointestinal stromal tumors, whereas heritable defects in the shelterin complex link susceptibility to sarcoma, melanoma, and thyroid cancers. These studies indicate a specific role for heritable defects in mitotic and telomere biology in risk of sarcomas.